The White House Council of Economic Advisers says the 'Pelosi plan' to curb prescription drug costs would reduce the number of new medicines by 100 and cut average life expectancy by about four months. …
Latest Video
New Stories
-
Mesoblast to launch pivotal adult trial for cell therapy in severe steroid-refractory GVHD
November 22, 2025 - - Australian Biotech -
Syntara launches Phase 2 trial aiming to teduce transfusion burden in myelodysplastic syndromes
November 22, 2025 - -
Alterity Therapeutics chairman reflects on two decades of progress as company enters new era
November 22, 2025 - - BioPharma -
Treasurer blocks US takeover of Mayne Pharma on national interest grounds
November 22, 2025 - - Latest News -
If the system properly applied results in harm, then the problem is worse than we think
November 20, 2025 - - Latest News -
Silence in response to unethical processes and outcomes is itself unethical
November 20, 2025 - - Latest News -
New analysis shows Telix's TLX250-CDx could change management of renal masses
November 20, 2025 - - Australian Biotech